J&J touts Icotyde prescriptions, but not sales, in first full quarter

July 15, 2026 10:35 AM EDT Pharma J&J's 'must-win launch' Ico­tyde nabs 18,000 pre­scrip­tions in first full quar­ter Max Gelman Senior Editor John­son & John­son teased some de­tails on Wednes­day morn­ing about how the launch of its ex­pect­ed block­buster Ico­tyde per­formed in the sec­ond quar­ter. With­out dis­clos­ing … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER